Aliment Pharmacol Ther

1. SCHEINER B, Dominik N, Mandorfer M
   Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply.
   Aliment Pharmacol Ther. 2024 Jul 3. doi: 10.1111/apt.18144.
   

   >> Share

   
   
2. KOUNTOURAS J, Polyzos SA, Kazakos E, Papanikolaou IS, et al
   Letter: Helicobacter pylori and metabolic syndrome-related von Willebrand factor and plasminogen activator inhibitor-1 activity levels for outcome prediction of advanced chronic liver disease.
   Aliment Pharmacol Ther. 2024 Jul 3. doi: 10.1111/apt.18066.
   

   >> Share

   
   

   
   Helicobacter

3. LI B, He J, Zhang R, Liu S, et al
   Integrin-Linked Kinase in the Development of Gastric Tumors Induced by Helicobacter pylori: Regulation and Prevention Potential.
   Helicobacter. 2024;29:e13109.
   

   >> Share

   
   
4. DORE MP, Meloni G, Bassu I, Pes GM, et al
   Helicobacter pylori Infection Does Not Protect Against Allergic Diseases: Evidence From a Pediatric Cohort From Northern Sardinia, Italy.
   Helicobacter. 2024;29:e13107.
   

   >> Share

   
   

   
   J Ethnopharmacol

5. KUMATIA EK, Antwi S, Asase A
   Analgesic and anti-inflammatory activities of NPK 500 capsules, a Cassia sieberiana DC. - Based herbal analgesic medicine used to treat dysmenorrhea and peptic ulcer, is mediated through the inhibition of PGE2 and iNOS.
   J Ethnopharmacol. 2024;333:118510.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share